RT Journal Article
SR Electronic
T1 Results from the Randomized PARTNER Trial (Cohort B)
JF MD Conference Express
YR 2011
FD SAGE Publications
VO 11
IS 3
SP 13
OP 14
DO 10.1177/155989771103004
UL http://mdc.sagepub.com/content/11/3/13.abstract
AB For patients with inoperable severe aortic stenosis, the incremental cost per life-year gained for transcatheter aortic valve replacement is in line with values for other cardiovascular technologies. This article presents these findings, which are based on a cost-effectiveness study of the PARTNER trial (Cohort B).